旋回萎缩的分子和细胞机制:为什么视网膜主要受影响?

IF 2.8 3区 医学 Q1 OPHTHALMOLOGY
Mark J N Buijs, Berith M Balfoort, Marion M Brands, Anneloor L M A Ten Asbroek, Camiel J F Boon, Roselie M H Diederen, Corrie Timmer, Margreet A E M Wagenmakers, Hans R Waterham, Ronald J A Wanders, Riekelt H Houtkooper, Clara D van Karnebeek, Arthur A Bergen
{"title":"旋回萎缩的分子和细胞机制:为什么视网膜主要受影响?","authors":"Mark J N Buijs, Berith M Balfoort, Marion M Brands, Anneloor L M A Ten Asbroek, Camiel J F Boon, Roselie M H Diederen, Corrie Timmer, Margreet A E M Wagenmakers, Hans R Waterham, Ronald J A Wanders, Riekelt H Houtkooper, Clara D van Karnebeek, Arthur A Bergen","doi":"10.1111/aos.17498","DOIUrl":null,"url":null,"abstract":"<p><p>Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early-onset autosomal recessive disorder, caused by bi-allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia. Clinically, GACR is characterized by the concentric loss of visual fields due to progressive chorioretinal atrophy. Because OAT is systemically expressed, it is not clear why primarily the retina is damaged in GACR patients. In this review, we first provide an extensive overview of the clinical features and current treatment modalities for GACR. Next, we discuss the different pathways involved in ornithine metabolism, including the urea cycle, polyamine synthesis, creatine synthesis, proline synthesis and degradation and provide our vision on how OAT deficiency is thought to affect these pathways in the retinal pigment epithelium (RPE). We provide several hypotheses to explain the retinal pathology observed in GACR and discuss perspectives on future research.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?\",\"authors\":\"Mark J N Buijs, Berith M Balfoort, Marion M Brands, Anneloor L M A Ten Asbroek, Camiel J F Boon, Roselie M H Diederen, Corrie Timmer, Margreet A E M Wagenmakers, Hans R Waterham, Ronald J A Wanders, Riekelt H Houtkooper, Clara D van Karnebeek, Arthur A Bergen\",\"doi\":\"10.1111/aos.17498\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early-onset autosomal recessive disorder, caused by bi-allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia. Clinically, GACR is characterized by the concentric loss of visual fields due to progressive chorioretinal atrophy. Because OAT is systemically expressed, it is not clear why primarily the retina is damaged in GACR patients. In this review, we first provide an extensive overview of the clinical features and current treatment modalities for GACR. Next, we discuss the different pathways involved in ornithine metabolism, including the urea cycle, polyamine synthesis, creatine synthesis, proline synthesis and degradation and provide our vision on how OAT deficiency is thought to affect these pathways in the retinal pigment epithelium (RPE). We provide several hypotheses to explain the retinal pathology observed in GACR and discuss perspectives on future research.</p>\",\"PeriodicalId\":6915,\"journal\":{\"name\":\"Acta Ophthalmologica\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-04-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Ophthalmologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/aos.17498\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Ophthalmologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/aos.17498","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

脉络膜和视网膜旋转萎缩(GACR);OMIM #258870)是一种罕见的早发常染色体隐性遗传病,由鸟氨酸转氨酶(OAT)基因编码的双等位致病变异引起高鸟氨酸血症。临床上,GACR的特征是由于进行性绒毛膜视网膜萎缩导致视野同心性丧失。由于OAT是全身表达的,所以目前尚不清楚为什么GACR患者主要是视网膜受损。在这篇综述中,我们首先对GACR的临床特征和目前的治疗方式进行了广泛的概述。接下来,我们讨论了参与鸟氨酸代谢的不同途径,包括尿素循环、多胺合成、肌酸合成、脯氨酸合成和降解,并提供了我们对OAT缺乏如何影响视网膜色素上皮(RPE)中这些途径的看法。我们提供了几种假设来解释在GACR中观察到的视网膜病理,并讨论了未来研究的观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?

Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early-onset autosomal recessive disorder, caused by bi-allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia. Clinically, GACR is characterized by the concentric loss of visual fields due to progressive chorioretinal atrophy. Because OAT is systemically expressed, it is not clear why primarily the retina is damaged in GACR patients. In this review, we first provide an extensive overview of the clinical features and current treatment modalities for GACR. Next, we discuss the different pathways involved in ornithine metabolism, including the urea cycle, polyamine synthesis, creatine synthesis, proline synthesis and degradation and provide our vision on how OAT deficiency is thought to affect these pathways in the retinal pigment epithelium (RPE). We provide several hypotheses to explain the retinal pathology observed in GACR and discuss perspectives on future research.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta Ophthalmologica
Acta Ophthalmologica 医学-眼科学
CiteScore
7.60
自引率
5.90%
发文量
433
审稿时长
6 months
期刊介绍: Acta Ophthalmologica is published on behalf of the Acta Ophthalmologica Scandinavica Foundation and is the official scientific publication of the following societies: The Danish Ophthalmological Society, The Finnish Ophthalmological Society, The Icelandic Ophthalmological Society, The Norwegian Ophthalmological Society and The Swedish Ophthalmological Society, and also the European Association for Vision and Eye Research (EVER). Acta Ophthalmologica publishes clinical and experimental original articles, reviews, editorials, educational photo essays (Diagnosis and Therapy in Ophthalmology), case reports and case series, letters to the editor and doctoral theses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信